1-propanol has been researched along with Diabetes Mellitus, Type 2 in 6 studies
1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This randomized, double-blind study was undertaken to compare the efficacy and tolerability of policosanol (10 mg/day) and lovastatin (20 mg/day) in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus." | 9.09 | Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus. ( Castaño, G; Crespo, N; Fernández, J; Fernández, L; Illnait, J; Más, R, 1999) |
| "This randomized, double-blind study was undertaken to compare the efficacy and tolerability of policosanol (10 mg/day) and lovastatin (20 mg/day) in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus." | 5.09 | Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus. ( Castaño, G; Crespo, N; Fernández, J; Fernández, L; Illnait, J; Más, R, 1999) |
| "Loss of muscle, known as muscle atrophy, causes the metabolic diseases such as type 2 diabetes mellitus, hypertension, and so on." | 1.72 | Cuban Policosanol Prevents the Apoptosis and the Mitochondrial Dysfunction Induced by Lipopolysaccharide in C2C12 Myoblast via Activation of Akt and Erk Pathways. ( An, JI; Cho, KH; Han, JW; Jeoung, NH; Jo, AL, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jo, AL | 1 |
| Han, JW | 1 |
| An, JI | 1 |
| Cho, KH | 1 |
| Jeoung, NH | 1 |
| Janikula, M | 1 |
| Pepping, J | 1 |
| Castaño, G | 2 |
| Menéndez, R | 1 |
| Más, R | 2 |
| Amor, A | 1 |
| Fernández, JL | 1 |
| González, RL | 1 |
| Lezcay, M | 1 |
| Alvarez, E | 1 |
| Torres, O | 1 |
| Agramonte, AJ | 1 |
| Illnait, J | 2 |
| Más Ferreiro, R | 1 |
| Fernández, L | 2 |
| Fernández, JC | 1 |
| Crespo, N | 1 |
| Fernández, J | 1 |
2 reviews available for 1-propanol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Policosanol: a new treatment for cardiovascular disease?
Topics: Anticholesteremic Agents; Cardiovascular System; Cholesterol, HDL; Cholesterol, LDL; Cuba; Diabetes | 2002 |
Policosanol.
Topics: Aged; Algorithms; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2 | 2003 |
3 trials available for 1-propanol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Topics: Aged; Anticholesteremic Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Alcohols; Fema | 2002 |
Treatment of hypercholesterolemia in NIDDM with policosanol.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Dia | 1995 |
Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
Topics: Anticholesteremic Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Alco | 1999 |
1 other study available for 1-propanol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Cuban Policosanol Prevents the Apoptosis and the Mitochondrial Dysfunction Induced by Lipopolysaccharide in C2C12 Myoblast via Activation of Akt and Erk Pathways.
Topics: Animals; Apoptosis; Cell Line; Diabetes Mellitus, Type 2; Fatty Alcohols; Lipopolysaccharides; MAP K | 2022 |